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ver the past decade, use of androgen deprivation therapy (ADT) to treat pros-
tate cancer has risen seven-fold, from 9.8% of patients in 1989-1992 to 74.6% 
in 1991-2001 (1).  ADT is used as neoadjuvant and adjuvant treatment with 
radiation therapy (RT), to treat recurrence following primary treatment with surgery 
or RT, or when the cancer is in an advanced stage at diagnosis. While ADT has demon-
strated survival benefits, it also is associated with increases in metabolic and cardio-
vascular risks.  Men receiving ADT have been shown to develop dyslipidemia, de-
creased arterial compliance, increased insulin resistance, weight gain with increased 
visceral fat deposition, decreased bone mineral density, decreased libido and erectile 
dysfunction, fatigue, cognitive changes and depression (1-12) 
Importantly, cardiovascular disease 
(CVD) is the leading non prostate-related 
cause of death among men with prostate 
cancer, accounting for 11-21% of deaths 
(13).  Men on ADT have a 20% higher risk 
of myocardial infarction (MI) and conges-
tive heart failure (CHF) than their coun-
terparts not on ADT (14). Also, data from 
the Prostate Cancer Outcomes Study 
(PCOS) (15) indicates that prolonged use 
of ADT increases the risk for diabetes and 
depression as well as risk of CVD and re-
lated MI and CHF (Penson, personal 
communication).  Further, Latino men 
are more likely to be diagnosed with later 
stage disease (16-25) and have been un-
derrepresented in previous studies.  La-
tino men in general have higher rates of 
metabolic syndrome, diabetes, obesity, 
and hypertension (28, 34-41).   
Additionally, we have found that La-
tino men start treatment for prostate can-
cer with lower health related quality of 
life (HRQOL) and that HRQOL declines 
over time for men on ADT relative to 
other treatments for prostate cancer (43). 
However, we have also found that these 
men are very interested in making 
changes that will improve their health, as 
are the wives of the married men (44).  Fi-
nally, we are finding that Latino men are 
unable to identify effects of ADT other 
than hot flashes and sexual dysfunction 
demonstrating a lack of awareness of the 
metabolic and cardiovascular effects of 
ADT.  Starting ADT may be a “teachable 
moment” to intervene with education 
and support for progressive individual-
ized behavioral changes to minimize car-
diovascular and metabolic effects of 
ADT.  Strategies which have been proven 
to improve risk profiles in other contexts 
are being used with this population. 
Presented here is a description of an 
NIH-funded randomized controlled trial 
of intervention to minimize cardiovascu-
lar and metabolic risk for Latino men on 
ADT.  Participants will be randomized 
O 
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into either an intervention group or an at-
tention control group.  Specifically, this 
study aims to: 
• Compare pre- and post-interven-
tion body mass index (BMI), lipid
profile, waist/hip circumference
and blood glucose levels within
and between groups
• Compare pre- and post-interven-
tion HRQOL and depression
within and between groups
• Develop and compare explana-
tory models of nutrition and ac-
tivity choices between groups
• Evaluate acceptability and benefit
of the intervention from partici-
pants’ perspective
Methods 
We are using a RCT design with the 
added feature of a constructivist 
grounded theory (20) component with a 
subset of 30 participants from the inter-
vention group and 30 from the attention 
control group.   
Recruitment 
We are recruiting 150 Latino men 
who have initiated ADT within the past 3 
months.  The study coordinator is work-
ing with office staff of urology clinics in a 
Midwestern city to identify participants 
who are potentially eligible for the study 
and obtain permission for study staff to 
contact the potential participant to ex-
plain the study.  Inclusion  
criteria are: 
• Self-identifies as Latino
• Within 3 months of starting ADT
• Diagnosed with prostate cancer
• Able to read and write in English
or Spanish
• Not prohibited from exercise by a
physician
Men identified by clinic staff and who 
give permission to be contacted, will re-
ceive a call from the bilingual (English-
Spanish) study coordinator to explain the 
study, determine eligibility, answer ques-
tions and obtain verbal consent.  Men will 
be randomized into the intervention or 
control group as they enroll. The study 
coordinator will contact consenting men 
to schedule the baseline visit at the trans-
lational research unit.  Men are encour-
aged to bring their partner or an adult 
child.  Assistance with transportation is 
provided if needed. 
Procedures 
Prior to the baseline visit, the study 
coordinator will contact all men and in-
struct them not to eat or drink after mid-
night before their visit.  The coordinator 
reviews the study, provides direction to 
the translational research unit and ascer-
tains whether transportation assistance is 
needed.  Men are greeted by the study co-
ordinator upon arrival, introduced to the 
study nurse, and taken to the unit for 
their blood draw.  Breakfast and beverage 
are then provided.  Next, the study nurse 
takes the participant’s blood pressure, 
and measures weight, height, waist and 
hip circumference. The study coordinator 
and study nurse then administer study 
instruments including general and dis-
ease-specific quality of life measures, a 
physical activity questionnaire, 24-hour 
food recall, and depression measure. 
This concludes baseline measures.  The 
same measures are repeated at six 
months and 12 months. 
Intervention 
At the baseline visit, those assigned to 
the intervention group receive a 
smartphone.  The study cultural liaison 
instructs men in the use of the phone.  All 
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materials for the intervention education 
curriculum have been preloaded onto the 
phone.  Men in the intervention group 
then receive a physical fitness assessment 
including upper and lower body strength 
and VO2 Max administered by co-I exer-
cise physiologist.  The assessment is then 
used to develop an individualized pro-
gress exercise plan and goals.  Similarly, 
a personalized nutrition plan and goals 
are developed from the nutrition assess-
ment. 
     Men and their significant other then 
receive a weekly call for three months 
from the study nurse and cultural liaison 
who is bilingual/bicultural utilizing the 
smartphone.  Each week there is an edu-
cational component, activity component, 
nutrition component, and discussion of 
goal setting relative to activity and nutri-
tion for the following week.  The educa-
tion topic for each week has been pre-
loaded onto the smartphone along with 
exercise demonstration videos.  Supple-
mental material can be sent to men as 
needed.  Co-Is consult with the study 
nurse on nutrition and activity for partic-
ipants as well any medical questions that 
arise.  Additionally, participants are re-
ferred to their primary physician when 
concerns arise. During the next three 
months, men receive a monthly call from 
the cultural liaison to monitor, assist, and 
coach with the nutrition and activity plan 
established at the end of the three months 
of weekly calls.  Men then return for the 
6-month data collection visit.  There is no
contact between the six-month and 12-
month data collection visits to ascertain
stability of intervention outcomes.
Qualitative Component 
A constructivist grounded theory ap-
proach is being utilized for this portion of 
the study to explore differences in deci-
sion-making processes related to nutri-
tion and activity between the two groups. 
A subsample of 30 men from each group 
will be purposively selected for semi-
structured interviews focusing on how 
they made choices about food selections 
and exercise.  Additionally, men in the in-
tervention group will be asked about 
their experience of the intervention in-
cluding what was and was not helpful, 
ease of use of the smartphone, and ability 
to set, accomplish, and maintain weekly 
goals.   
Analysis 
Analysis will include both quantita-
tive and qualitative techniques.  Prelimi-
nary analysis will include descriptive sta-
tistics for each measure at each time 
point, assessment of distributional char-
acteristics including outliers, evaluation 
of missing data, and assessment of relia-
bility.  Intervention and control groups 
will be compared for baseline equiva-
lence on metabolic indicators and 
HRQOL, as well as other selected factors 
(e.g. sociodemographics, co-morbidities, 
medications, primary prostate cancer 
treatment, acculturation, diet and activity 
indicators, etc.) using t-tests or chi square 
tests relevant to the distributional charac-
teristics.  The correlation of these possible 
covariates to the outcome measures will 
also be examined. 
     Analyses for the first aim will com-
pare groups in terms of their change in 
metabolic indicators over time using a 
mixed effects model for repeated 
measures, in which group is considered a 
fixed between-group factor (101, 108). 
This approach will allow inclusion of co-
variates determined in preliminary anal-
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yses in order to adjust for baseline indi-
vidual differences that might impact pat-
terns over time.  This will also allow for 
inclusion of all available data points for 
each individual, even if the data vector is 
incomplete due to attrition.  Each out-
come indicator will be considered a de-
pendent variable in separate models.  In 
these models, the group-by-time interac-
tion term will be examined to determine 
differences between groups over time. 
Additional contrasts will examine the 
shape of the pattern of change over time 
within each group, specific changes from 
baseline to 6 months and baseline to 12 
months within each group, and the dif-
ference between groups at each observa-
tion point. Interaction effects will allow 
further examination of covariate relation-
ships to these differences over time.  A 
similar approach will be used to address 
the second aim with HRQOL and dis-
ease-specific HRQOL as dependent vari-
ables. 
The third and fourth aims will be met 
through qualitative analysis of inter-
views conducted at the 12-month data 
collection visit using grounded theory 
techniques (Charmaz 2006). All inter-
views will be audio-recorded and tran-
scribed verbatim.  Transcripts will be en-
tered into Atlas ti.v2 for data manage-
ment.  Initially, the PI will read tran-
scripts in their entirety and proceed to 
segment-by-segment coding.  Related 
codes will be clustered and developed 
into categories describing process used 
by participants to make food and activity 
choices. The study team will inde-
pendently code several of the same tran-
scripts and meet to confer and agree on 
categories.  The team will then continue 
coding and categorizing with periodic 
meetings to develop full description for 
each category that includes properties 
and dimensions and identify relation-
ships among categories.  For the interven-
tion group, we will explore categories for 
explanations of adherence and non-ad-
herence.  We will also compare the ex-
planatory frameworks developed for 
each group relative to nutrition and activ-
ity decision making.  These explanatory 
frameworks will be used to contextualize 
the interpretation of the outcome 
measures taking into account partici-
pants’ decision process, context factors 
which influenced outcomes, perception 
of importance and relationship of nutri-
tion and activity to HRQOL and health 
during ADT. 
Institutional Transitioning of the 
Study 
At this point, the study is in transition 
between two major universities.  The pro-
cess is a lengthy and complex one which 
demands constant communication.  An 
initial step involved identifying the re-
sources and technology at the new insti-
tution necessary to conduct the study. 
This included building the infrastructure 
with new co-investigators, consultants, 
as well as hiring a new research manager 
and research staff. Fortunately, the re-
sources and expertise were available at 
the new institution and there has been 
immense support from interdisciplinary 
teams.  
       As recruitment is pertinent to study 
success, it was necessary to be proactive 
about understanding where the potential 
participant pool of Latino men starting 
ADT would be coming from. We found 
that this pool was much smaller at the 
new university; however, an African 
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American population was more abun-
dant.  We thought it would be interesting 
to explore this underrepresented popula-
tion as well, and thus, were granted per-
mission by the NIH to expand our re-
cruitment to men of any ethnicity.  The 
new team has been able to identify strat-
egies for recruitment which include 
working with local urology clinics and 
community groups for the identification 
and potential enrollment of participants. 
During this time, study work at the orig-
inal institution was being transitioned 
from recruitment to preparing for the 
transfer of the study. 
     Mechanisms for transfer of data collec-
tion procedures, documentation, track-
ing, storage and management had to be 
developed. This continues to involve col-
laboration and communication between 
many different parties, including but not 
limited to the research manager at the 
new institution with the study staff at the 
transferring institution, as well as medi-
cal informatics at the new institution to 
build the framework for data collection 
and storage.  Additionally, study equip-
ment such as smartphones, resistance 
bands, heart rate monitors, and gift cards 
for participants had to be moved from 
one institution to the other.   
     Finally, there has been ongoing com-
munication with the NIH to meet re-
quirements for relinquishment of the 
grant by the original institution and ac-
ceptance by the new institution.  There 
have been both formal and informal com-
munications to accomplish this.  This has 
included reformulation of the study 
budget, modification of methods to fit the 
new site, and obtaining IRB approval at 
the new institution.  During this time, re-
cruitment and study activities have had 
to be suspended until the grant is offi-
cially transferred to the new institution. 
As there are many moving parts involved 
in building a new infrastructure and de-
veloping resources while maintaining 
communication with the original site and 
overseeing transitional processes, we 
have come across unforeseen limitations. 
Fortunately, these hurdles have provided 
opportunities to learn, grow, and develop 
new processes to benefit the future of the 
study.  While it has been an arduous pro-
cess, we have learned that maintaining 
close and open communication among all 
parties is critical to a successful grant 
transition.  
Recommendations 
Primarily, communication is essen-
tial.  As soon as it is known that a PI will 
be requesting to transfer a grant, it is im-
perative that he/she has a discussion with 
the current institution’s dean or associate 
dean for research and with the counter-
part at the receiving institution.  Being 
proactive about and maintaining quality 
communication is necessary for both in-
stitutions.  Concurrently, the PI can be in-
forming the study program officer of the 
impending transfer and seek guidance as 
to NIH process requirements.  Under-
standing the NIH guidelines up front will 
help for a smoother transition.  Next, op-
timal timing for relinquishment and ac-
ceptance can be determined such that 
budgetary modifications can be negoti-
ated and approved with minimal loss of 
time for study activities.  These timelines 
will dictate when it is appropriate to ship 
materials to the new site as well as data 
and systems transfers. The goal of a grant 
transfer is to have everything in place at 
the new institution in order to start study 
activities as soon as the transfer is official. 
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In addition to starting procedures and 
data collection at the new site, it is just as 
important to accommodate completion of 
study participants at the original site with 
smooth closeout operating procedures.   
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